Residual Cardiovascular Risk and Triglycerides
The main interventions nowadays in the presence of abnormal lipid levels in order to reduce the risk of CVD are the reductions of Total Cholesterol and Low Density Lipoprotein-Cholesterol.
However, all the studies (clinical and survival) have shown that when the elevated levels of total and LDL cholesterol are reduced by lipid-lowering drugs, the cardiovascular mortality and total mortality are decreased by 30% -40%.
This means that most patients, despite receiving the best available medical treatment, continue to be at increased risk for cardiovascular diseases (myocardial infarction and stroke).
Nowadays, the elevated plasma triglyceride level is an independent risk factor for cardiovascular diseases and there are many epidemiological studies to confirm it.